CDKN2A and Cyclin D1 in Malignant Gliomas
Author Information
Author(s): Liu Weidong, Lv Guohua, Li Yawei, Li Lei, Wang Bing
Primary Institution: Department of Spinal Surgery, Second Xiangya Hospital, Central South University
Hypothesis
The expression of CDKN2A correlates with the grade of malignant gliomas and plays a role in their pathogenesis.
Conclusion
CDKN2A acts as a suppressor gene in malignant gliomas and may help predict the behavior of high-grade tumors.
Supporting Evidence
- Lower expression of CDKN2A was found in high-grade gliomas compared to low-grade gliomas.
- Overexpression of CDKN2A inhibited the growth of glioma cell lines.
- The study suggests that CDKN2A may be a useful marker for predicting the behavior of high-grade malignant gliomas.
Takeaway
This study found that lower levels of a gene called CDKN2A are linked to more aggressive brain tumors, and boosting this gene could help slow down tumor growth.
Methodology
The study analyzed tumor samples from 61 patients using immunohistochemical staining and western blot to assess CDKN2A expression.
Participant Demographics
Patients included 26 with low-grade gliomas and 35 with high-grade gliomas, with a mix of male and female participants.
Statistical Information
P-Value
p<0.01
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website